Corporate ManufacturerCached Profile

OTSUKA PHARMACEUTICAL DEVELOPMENT & COMMERCIALIZATION

Manufacturer Corporate ID: 100000010725

Subsidiaries Logged: 1 entities

LIFETIME CORPORATE SPEND

$7,670,650

General Payments Aggregated (2021–2025)

Data coverage: 2021 – 2025 · Source: CMS Open Payments · CMS publishes each year's data around June 30 of the following year.

Physicians receiving the highest promotional payments from this corporation.

$1,563,836

2. Dr. KEVIN COXMedical Doctor

$976,997

3. Dr. LINDA CAPPIELLO-LINDSLEYMedical Doctor

$973,868

4. Dr. HASSAN MALIKMedical Doctor

$562,040

5. Dr. HAOLING WENGMedical Doctor

$407,089

Drugs or medical devices receiving the highest marketing backing.

1. REXULTI$1,360,060 (17.7%)

2. TOLVAPTAN$805,744 (10.5%)

4. REJOYN$90,028 (1.2%)

5. JYNARQUE$32,322 (0.4%)

Corporate subsidiaries and brands associated with this manufacturer ID in Open Payments.

OTSUKA PHARMACEUTICAL DEVELOPMENT & COMMERCIALIZATION, INC.

Federal registry records of promotional speaking, consulting, meals, and offsets.

Year:

2025

Filter < $250

Querying Open Payments Database

Fetching live CMS.gov records for OTSUKA PHARMACEUTICAL DEVELOPMENT & COMMERCIALIZATION...